Advertisement|Remove ads.

Inspire Veterinary Partners (IVP) stock gained spotlight on Monday amid a potential delisting possibility after receiving a formal warning from Nasdaq’s Listing Qualifications Department.
Inspire Veterinary Partners owns and operates animal care clinics across the United States.
On Nov, 13, 2025, the company was notified that its common stock failed to maintain the required minimum bid price over 30 consecutive business days, putting it in violation of the Nasdaq Listing Rule.
The notice also cited that Inspire is ineligible for any cure period because it has carried out reverse stock splits totaling a ratio of 250-to-1 or more over the past two years.
Inspire Veterinary Partners’ stock traded over 52% higher in Monday’s premarket. On Stocktwits, retail sentiment around the stock remained in ‘extremely bullish’ territory amid ‘extremely high’ message volume levels.
The notification said that unless Inspire appeals to Nasdaq’s Hearings Panel by Nov. 20, 2025, its shares may be suspended from trading beginning Nov. 24, 2025.
Earlier in 2025, Inspire completed a 1-for-25 reverse stock split, a move likely made to help lift its share price above the minimum threshold. The company has also carried out a prior 1-for-100 split in May 2024.
For the third quarter, the company’s revenue rose by 7% year-on-year (YoY) to $4.3 million, net losses fell by 27% YoY, and revenue at comparable clinics grew 9.2% YoY.
In October, Inspire Veterinary announced the launch of an online pet pharmacy to give veterinarians and pet owners access to a wide range of prescription and over-the-counter pet care products.
Also See: Quantum-Enabled Drones: IonQ And Heven Forge Defense Alliance
For updates and corrections, email newsroom[at]stocktwits[dot]com.